Approval · Notice of Compliance 1219 · 2000
OPTIRAY: Notice of Compliance 1219
Issued August 17, 2000
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1219
- Date
- August 17, 2000
- Company
- Mallinckrodt MedicalAthlone, WM, Ireland
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Alternate method for synthesis of loversol (asi)
- Therapeutic class
- Radiopaque contrast medium
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| OPTIRAY | Not yet assigned | — |